Journal article · 2020 · Open access

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Friederike Holze, Patrick Vizeli, Laura Ley, Felix Müller, Patrick C. Dolder, Melanie Stocker, Urs Duthaler, Nimmy Varghese, Anne Eckert, Stefan Borgwardt, Matthias E. Liechti

Neuropsychopharmacology, 46(3), 537–544 · Published 15 October 2020 · DOI 10.1038/s41386-020-00883-6

Open PDFView at the publisherCite this paper

In brief

“Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects” is a 2020 journal article by Friederike Holze and 10 co-authors, published in Neuropsychopharmacology. OpenAlex counts 269 citations as of 18 November 2026, which puts it in the top 7% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Neuropsychopharmacology.

Citations
269
Most cited in
2025 (65)
Field-weighted impact
10.57
References
42
Authors
11

Abstract

Growing interest has been seen in using lysergic acid diethylamide (LSD) in psychiatric research and therapy. However, no modern studies have evaluated subjective and autonomic effects of different and pharmaceutically well-defined doses of LSD. We used a double-blind, randomized, placebo-controlled, crossover design in 16 healthy subjects (eight women, eight men) who underwent six 25 h sessions and received placebo, LSD (25, 50, 100, and 200 µg), and 200 µg LSD 1 h after administration of the serotonin 5-hydroxytryptamine-2A (5-HT 2A ) receptor antagonist ketanserin (40 mg). Test days were separated by at least 10 days. Outcome measures included self-rating scales that evaluated subjective effects, autonomic effects, adverse effects, plasma brain-derived neurotrophic factor levels, and pharmacokinetics up to 24 h. The pharmacokinetic-subjective response relationship was evaluated. LSD showed dose-proportional pharmacokinetics and first-order elimination and dose-dependently induced subjective responses starting at the 25 µg dose. A ceiling effect was observed for good drug effects at 100 µg. The 200 µg dose of LSD induced greater ego dissolution than the 100 µg dose and induced significant anxiety. The average duration of subjective effects increased from 6.7 to 11 h with increasing doses of 25–200 µg. LSD moderately increased blood pressure and heart rate. Ketanserin effectively prevented the response to 200 µg LSD. The LSD dose–response curve showed a ceiling effect for subjective good effects, and ego dissolution and anxiety increased further at a dose above 100 µg. These results may assist with dose finding for future LSD research. The full psychedelic effects of LSD are primarily mediated by serotonin 5-HT 2A receptor activation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Holze, F., Vizeli, P., Ley, L., Müller, F., Dolder, P. C., Stocker, M., Duthaler, U., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020). Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology, 46(3), 537–544. https://doi.org/10.1038/s41386-020-00883-6

MLA 9

Holze, Friederike, et al. “Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.” Neuropsychopharmacology, vol. 46, no. 3, 2020, pp. 537–544. https://doi.org/10.1038/s41386-020-00883-6.

Chicago

Holze, Friederike, Patrick Vizeli, Laura Ley, Felix Müller, Patrick C. Dolder, Melanie Stocker, Urs Duthaler, et al. 2020. “Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.” Neuropsychopharmacology 46 (3): 537–544. https://doi.org/10.1038/s41386-020-00883-6.

Harvard

Holze, F. et al. (2020) ‘Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects’, Neuropsychopharmacology, 46(3), pp. 537–544. doi:10.1038/s41386-020-00883-6.

IEEE

F. Holze et al., “Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects,” Neuropsychopharmacology, vol. 46, no. 3, pp. 537–544, 2020, doi: 10.1038/s41386-020-00883-6.

BibTeX

@article{holze2020acute,
  title     = {{Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects}},
  author    = {Holze, Friederike and Vizeli, Patrick and Ley, Laura and Müller, Felix and Dolder, Patrick C. and Stocker, Melanie and Duthaler, Urs and Varghese, Nimmy and Eckert, Anne and Borgwardt, Stefan and Liechti, Matthias E.},
  journal   = {Neuropsychopharmacology},
  year      = {2020},
  volume    = {46},
  number    = {3},
  pages     = {537--544},
  doi       = {10.1038/s41386-020-00883-6},
  url       = {https://doi.org/10.1038/s41386-020-00883-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202022
20213030
20225252
20233636
20244949
20256565
20263535

Its field-weighted citation impact is 10.57: it has been cited 10.57 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies

  • lysergic acid diethylamide
  • LSD
  • dose-response relationship
  • 5-HT2A receptor
  • ketanserin
  • ego dissolution
  • anxiety
  • subjective effects

Work with this paper

Most-cited papers in Psychology

All highly cited Psychology papers

Questions about this paper

How do I cite this paper in APA style?

Holze, F., Vizeli, P., Ley, L., Müller, F., Dolder, P. C., Stocker, M., Duthaler, U., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020). Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology, 46(3), 537–544. https://doi.org/10.1038/s41386-020-00883-6

How many times has this paper been cited?

269 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Neuropsychopharmacology: sign in and open the PDF from this page.

Who wrote this paper?

Friederike Holze, Patrick Vizeli, Laura Ley, Felix Müller, Patrick C. Dolder, Melanie Stocker, Urs Duthaler, Nimmy Varghese, Anne Eckert, Stefan Borgwardt, Matthias E. Liechti.

What is the DOI of this paper?

10.1038/s41386-020-00883-6, permanently at https://doi.org/10.1038/s41386-020-00883-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.